Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Angelini

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Heart Failure|January 22, 2025
The DIGIT-HF trial: Key amendments of study designUdo Bavendiek, Dominik Berliner, Nele Henrike Thomas, et al.
European Journal of Heart Failure|May 19, 2025
DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trialsUdo Bavendiek, Nele Henrike Thomas, Dominik Berliner, et al.
The New England Journal of Medicine|August 29, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection FractionUdo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Heart Failure|January 22, 2025
The DIGIT-HF trial: Key amendments of study designUdo Bavendiek, Dominik Berliner, Nele Henrike Thomas, et al.
European Journal of Heart Failure|May 19, 2025
DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trialsUdo Bavendiek, Nele Henrike Thomas, Dominik Berliner, et al.
The New England Journal of Medicine|August 29, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection FractionUdo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
Pageof 2